The Incidental Discovery of Follicular Thyroid Cancer with In-111 Pentetreotide Scintigraphy in a Patient with Carcinoid Tumor of the Lung

Clinical Nuclear Medicine

Volumn 28, Issue 1, 2003, Pages 45-46

  Villa, Giuseppe ^a,b   Ratto, Giovanni B ^b   Carletto, Marco ^b   Rouhanifar, Hamed ^b   Piccardo, Arnoldo ^b   Tommasi, Luigi ^b   Altrinetti, Vania ^b   Mereu, Carlo ^b   Mariani, Giuliano ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Carcinoid Tumor; Follicular Thyroid Cancer; In 111 Pentetreotide; Somatostatin Receptor Scintigraphy

Indexed keywords

PENTETREOTIDE IN 111; RADIOPHARMACEUTICAL AGENT; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; PENTETREOTIDE; SOMATOSTATIN;

ADULT; AMINATION; ARTICLE; ASPIRATION BIOPSY; CALCITONIN BLOOD LEVEL; CANCER SCINTISCANNING; CARCINOID; CASE REPORT; CYTODIAGNOSIS; DECARBOXYLATION; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; INCIDENTAL FINDING; ISOTOPE LABELING; LUNG CARCINOMA; LUNG RESECTION; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROIDECTOMY; ADENOCARCINOMA; LUNG TUMOR; MULTIPLE CANCER; SCINTISCANNING; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADULT; CARCINOID TUMOR; FEMALE; HUMANS; INCIDENTAL FINDINGS; INDIUM RADIOISOTOPES; LUNG NEOPLASMS; NEOPLASMS, MULTIPLE PRIMARY; RADIOPHARMACEUTICALS; SOMATOSTATIN; THYROID NEOPLASMS;

EID: 0037209119     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200301000-00012     Document Type: Article

References (7)

1. Lamberts SWJ, Bakker WH, Reubi JC, et al: Somatostatin-receptor imaging in the localization of endocrine tumors. N Engl J Med 323:652, 1990.
2. O'Byrne KJ, O'Hare N, Sweeney E, et al: Somatostatin and somatostatin analogues in medullary thyroid carcinoma. Nucl Med Commun 17:810, 1996.
3. Garancini S, La Rosa S, De Palma D, et al: Uptake of In-111 pentetreotide by normally functioning nodular goiters. Clin Nucl Med 22:625, 1997.
4. Limouris GS, Rassidakis A, Kondi-Paphiti A, et al: Somatostatin receptor scintigraphy of non-neuroendocrine malignancies with 111In-pentetreotide. Anticancer Research 17:1593, 1997.
5. Forssell-Aronsson EB, Nilsson O, Bejegard SA, et al: 111-In DTPA-D-Phel-octreotide binding and somatostatin receptor subtypes in thyroid tumors. J Nucl Med 41:636, 2000.
6. Gorges R, Kahaly G, Muller Brand J, et al: A. Somatostatin receptor status in non-medullary thyroid carcinoma. Nuklearmedizin 38:15, 1999.
7. Gorges R, Kahaly G, Muller Brand J, et al: Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer. Thyroid 11:647, 2001.